AU2001234462A1 - Antisense modulation of cot oncogene expression - Google Patents
Antisense modulation of cot oncogene expressionInfo
- Publication number
- AU2001234462A1 AU2001234462A1 AU2001234462A AU3446201A AU2001234462A1 AU 2001234462 A1 AU2001234462 A1 AU 2001234462A1 AU 2001234462 A AU2001234462 A AU 2001234462A AU 3446201 A AU3446201 A AU 3446201A AU 2001234462 A1 AU2001234462 A1 AU 2001234462A1
- Authority
- AU
- Australia
- Prior art keywords
- cot
- antisense modulation
- oncogene expression
- oncogene
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108700020796 Oncogene Proteins 0.000 title 1
- 230000000692 anti-sense effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01037—Protein kinase (2.7.1.37)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/334—Modified C
- C12N2310/3341—5-Methylcytosine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/341—Gapmers, i.e. of the type ===---===
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/346—Spatial arrangement of the modifications having a combination of backbone and sugar modifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/489,868 US6265216B1 (en) | 2000-01-20 | 2000-01-20 | Antisense modulation of cot oncogene expression |
US09489868 | 2000-01-20 | ||
PCT/US2001/001417 WO2001052864A1 (en) | 2000-01-20 | 2001-01-16 | Antisense modulation of cot oncogene expression |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001234462A1 true AU2001234462A1 (en) | 2001-07-31 |
Family
ID=23945594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001234462A Abandoned AU2001234462A1 (en) | 2000-01-20 | 2001-01-16 | Antisense modulation of cot oncogene expression |
Country Status (3)
Country | Link |
---|---|
US (2) | US6265216B1 (en) |
AU (1) | AU2001234462A1 (en) |
WO (1) | WO2001052864A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100282634A1 (en) * | 2000-11-17 | 2010-11-11 | Dror Harats | Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis |
US8071740B2 (en) * | 2000-11-17 | 2011-12-06 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
US8039261B2 (en) * | 2000-11-17 | 2011-10-18 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
US20070286845A1 (en) * | 2000-11-17 | 2007-12-13 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
AU2003222427B8 (en) | 2000-11-17 | 2010-04-29 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same |
US6838452B2 (en) | 2000-11-24 | 2005-01-04 | Vascular Biogenics Ltd. | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
US20040086875A1 (en) * | 2001-11-05 | 2004-05-06 | Agee Michele L. | Novel proteins and nucleic acids encoding same |
US7033790B2 (en) * | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
US20040038223A1 (en) * | 2001-10-02 | 2004-02-26 | Glennda Smithson | Novel proteins and nucleic acids encoding same |
EP2277887A3 (en) | 2001-10-19 | 2011-02-16 | Vascular Biogenics Ltd. | Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
-
2000
- 2000-01-20 US US09/489,868 patent/US6265216B1/en not_active Expired - Lifetime
-
2001
- 2001-01-16 US US10/181,873 patent/US20030212019A1/en not_active Abandoned
- 2001-01-16 AU AU2001234462A patent/AU2001234462A1/en not_active Abandoned
- 2001-01-16 WO PCT/US2001/001417 patent/WO2001052864A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US6265216B1 (en) | 2001-07-24 |
WO2001052864A1 (en) | 2001-07-26 |
US20030212019A1 (en) | 2003-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001289085A1 (en) | Antisense modulation of flip-c expression | |
AU2001294926A1 (en) | Antisense modulation of smad6 expression | |
AU2001229493A1 (en) | Antisense modulation of mekk2 expression | |
AU2001289046A1 (en) | Antisense modulation of her-2 expression | |
AU2212600A (en) | Antisense modulation of g-alpha-i1 expression | |
AU6296099A (en) | Antisense modulation of g-alpha-12 expression | |
AU2001277054A1 (en) | Antisense modulation of lysophospholipase i expression | |
AU2001229447A1 (en) | Antisense modulation of smad7 expression | |
AU2001261808A1 (en) | Antisense modulation of pten expression | |
AU2001263171A1 (en) | Antisense modulation of tert expression | |
AU2001239971A1 (en) | Antisense modulation of parp expression | |
AU2001227847A1 (en) | Antisense modulation of pepck-cytosolic expression | |
AU6115400A (en) | Antisense modulation of mekk5 expression | |
AU2002366788A1 (en) | Antisense modulation of ship-1 expression | |
AU2001288968A1 (en) | Antisense modulation of btak expression | |
AU2001283443A1 (en) | Antisense modulation of hpk/gck-like kinase expression | |
AU2001234462A1 (en) | Antisense modulation of cot oncogene expression | |
AU2002318139A1 (en) | Antisense modulation of src-c expression | |
AU2002230869A1 (en) | Antisense modulation of hepsin expression | |
AU2209000A (en) | Antisense modulation of pepck-mitochondrial expression | |
AU2002226064A1 (en) | Antisense modulation of talin expression | |
AU5486700A (en) | Antisense modulation of g-alpha-s1 expression | |
AU2002357102A1 (en) | Antisense modulation of cd36l1 expression | |
AU2001287136A1 (en) | Antisense modulation of glioma-associated oncogene-1 expression | |
AU2410600A (en) | Antisense modulation of g-alpha-i3 expression |